A study to investigate the pharmacokinetics of a single inhaled dose (400mcg) of GW685698X [fluticasone furoate] and its effect on serum cortisol in patients with impaired liver function and matched control subjects.

Trial Profile

A study to investigate the pharmacokinetics of a single inhaled dose (400mcg) of GW685698X [fluticasone furoate] and its effect on serum cortisol in patients with impaired liver function and matched control subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Fluticasone furoate (Primary)
  • Indications Asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis; Sinusitis
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 06 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top